Tang et al. demonstrated that both pharmacological and genetic inhibition of ULK1 in NSCLC resulted in decreased cell proliferation, increased apoptosis, and an increased sensitivity to cisplatin25. The gene discussed is ULK1; the disease is non-small cell lung carcinoma.